{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:29:40Z","timestamp":1791948580691,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"am","delay-in-days":328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["VR-36"],"award-info":[{"award-number":["VR-36"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["VR-12"],"award-info":[{"award-number":["VR-12"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2 TR002317"],"award-info":[{"award-number":["KL2 TR002317"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1 TR002318"],"award-info":[{"award-number":["TL1 TR002318"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR002319"],"award-info":[{"award-number":["UL1 TR002319"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30AI027757"],"award-info":[{"award-number":["P30AI027757"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R44DA044053"],"award-info":[{"award-number":["R44DA044053"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013347","name":"Institute of Translational Health Sciences, University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005227","name":"Centers for Medicare and Medicaid Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006370","name":"Small Business Innovation Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.josat.2022.208934","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T12:23:07Z","timestamp":1673007787000},"page":"208934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Methamphetamine use and illicit opioid use during buprenorphine treatment"],"prefix":"10.1016","volume":"151","author":[{"given":"Zo\u00eb","family":"Kratina-Hathaway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea C.","family":"Radick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendra","family":"Blalock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa W.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Darnton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Saxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Samet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith I.","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.josat.2022.208934_bb0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archinternmed.2010.541","article-title":"Collaborative care of opioid-addicted patients in primary care using buprenorphine: Five-year experience","volume":"171","author":"Alford","year":"2011","journal-title":"Archives of Internal Medicine"},{"issue":"8","key":"10.1016\/j.josat.2022.208934_bb0010","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1080\/10826084.2016.1271432","article-title":"Heroin and methamphetamine injection: An emerging drug use pattern","volume":"52","author":"Al-Tayyib","year":"2017","journal-title":"Substance Use and Misuse"},{"issue":"1","key":"10.1016\/j.josat.2022.208934_bb0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/ADM.0000000000000669","article-title":"\"Like yin and Yang\": Perceptions of methamphetamine benefits and consequences among people who use opioids in rural communities","volume":"15","author":"Baker","year":"2021","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2022.208934_bb0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7326\/M20-1210","article-title":"When epidemics collide: Coronavirus disease 2019 (COVID-19) and the opioid crisis","volume":"173","author":"Becker","year":"2020","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/j.josat.2022.208934_bb0025","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1186\/s12879-020-05464-y","article-title":"Risk factors associated with infection of blood-borne virus among people who used methamphetamine","volume":"20","author":"Cai","year":"2020","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.josat.2022.208934_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2020.106655","article-title":"Long term pre-treatment opioid use trajectories in relation to opioid agonist therapy outcomes among people who use drugs in a Canadian setting","volume":"112","author":"Dong","year":"2021","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.josat.2022.208934_bb0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2018.08.029","article-title":"Twin epidemics: The surging rise of methamphetamine use in chronic opioid users","volume":"193","author":"Ellis","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2022.208934_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13011-021-00350-5","article-title":"'Resurgent', 'twin' or 'silent' epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America","volume":"16","author":"Fischer","year":"2021","journal-title":"Substance Abuse Treatment, Prevention and Policy"},{"issue":"1","key":"10.1016\/j.josat.2022.208934_bb0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13722-021-00266-2","article-title":"The impact of methamphetamine\/amphetamine use on receipt and outcomes of medications for opioid use disorder: A systematic review","volume":"16","author":"Frost","year":"2021","journal-title":"Addiction Science & Clinical Practice"},{"issue":"34","key":"10.1016\/j.josat.2022.208934_bb0050","doi-asserted-by":"crossref","first-page":"737","DOI":"10.15585\/mmwr.mm6834a2","article-title":"Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine - 25 states, July-December 2017 to January-June 2018","volume":"68","author":"Gladden","year":"2019","journal-title":"MMWR; Morbidity and Mortality Weekly Report"},{"issue":"2","key":"10.1016\/j.josat.2022.208934_bb0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/ajad.13115","article-title":"Increasing heroin-methamphetamine (Goofball) use and related morbidity among Seattle area people who inject drugs","volume":"30","author":"Glick","year":"2021","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.josat.2022.208934_bb0060","first-page":"1","article-title":"Drug overdose deaths in the United States, 1999\u20132017","volume":"329","author":"Hedegaard","year":"2018","journal-title":"NCHS Data Brief"},{"issue":"3","key":"10.1016\/j.josat.2022.208934_bb0065","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/08897077.2019.1635557","article-title":"Engaging an unstably housed population with low-barrier buprenorphine treatment at a syringe services program: Lessons learned from SeattleWashington","volume":"41","author":"Hood","year":"2020","journal-title":"Subst Abus"},{"issue":"3","key":"10.1016\/j.josat.2022.208934_bb0070","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/MLR.0000000000001460","article-title":"Service involvement across multiple sectors among people who use opioids, methamphetamine, or both, United States-2015-2018","volume":"59","author":"Howell","year":"2021","journal-title":"Medical Care"},{"key":"10.1016\/j.josat.2022.208934_bb0075","article-title":"Behavioral risk factors for HIV infection in hospitalized persons who co-use stimulants and opioids","author":"Jawa","year":"2021","journal-title":"AIDS and Behavior"},{"issue":"2","key":"10.1016\/j.josat.2022.208934_bb0080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/add.14812","article-title":"Increases in methamphetamine use among heroin treatment admissions in the United States, 2008\u201317","volume":"115","author":"Jones","year":"2020","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.josat.2022.208934_bb0085","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00004479-200107000-00011","article-title":"Health status assessments using the veterans SF-12 and SF-36: Methods for evaluating outcomes in the veterans health administration","volume":"24","author":"Jones","year":"2001","journal-title":"The Journal of Ambulatory Care Management"},{"key":"10.1016\/j.josat.2022.208934_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108329","article-title":"Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings","volume":"126","author":"Krawczyk","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"6","key":"10.1016\/j.josat.2022.208934_bb0095","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths - United States, 2013\u20132019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR; Morbidity and Mortality Weekly Report"},{"issue":"5","key":"10.1016\/j.josat.2022.208934_bb0100","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1080\/09595230801914776","article-title":"Impaired physical health among methamphetamine users in comparison with the general population: The role of methamphetamine dependence and opioid use","volume":"27","author":"McKetin","year":"2008","journal-title":"Drug and Alcohol Review"},{"issue":"3","key":"10.1016\/j.josat.2022.208934_bb0105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the Addiction Severity Index","volume":"9","author":"McLellan","year":"1992","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2022.208934_bb0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jsat.2020.01.010","article-title":"Hospitalization outcomes of people who use drugs: One size does not fit all","volume":"112","author":"Merchant","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2022.208934_bb0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.drugalcdep.2018.06.017","article-title":"HIV infection among MSM who inject methamphetamine in 8 US cities","volume":"190","author":"Nerlander","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"35","key":"10.1016\/j.josat.2022.208934_bb0120","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.15585\/mmwr.mm6935a1","article-title":"Vital signs: Characteristics of drug overdose deaths involving opioids and stimulants - 24 states and the District of Columbia, january-june 2019","volume":"69","author":"O'Donnell","year":"2020","journal-title":"MMWR; Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.josat.2022.208934_bb0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drugalcdep.2019.03.009","article-title":"Effect of lowering initiation thresholds in a primary care-based buprenorphine treatment program","volume":"200","author":"Payne","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.josat.2022.208934_bb0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jpsychores.2012.06.001","article-title":"The PHQ-9 versus the PHQ-8\u2013Is item 9 useful for assessing suicide risk in coronary artery disease patients? Data from the heart and soul study","volume":"73","author":"Razykov","year":"2012","journal-title":"Journal of Psychosomatic Research"},{"issue":"1","key":"10.1016\/j.josat.2022.208934_bb0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13722-020-00203-9","article-title":"Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: Protocol for a pilot randomized controlled trial","volume":"15","author":"Schramm","year":"2020","journal-title":"Addiction Science & Clinical Practice"},{"issue":"10","key":"10.1016\/j.josat.2022.208934_bb0140","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: The GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.josat.2022.208934_bb0145","series-title":"Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health","year":"2019"},{"issue":"1","key":"10.1016\/j.josat.2022.208934_bb0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1521-0391.2009.00003.x","article-title":"The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine\/naloxone for the treatment of opioid dependence","volume":"19","author":"Sullivan","year":"2010","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.josat.2022.208934_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108917","article-title":"Video directly observed therapy for patients receiving office-based buprenorphine - A pilot randomized controlled trial","volume":"227","author":"Tsui","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2022.208934_bb0160","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jsat.2019.10.005","article-title":"Association between methamphetamine use and retention among patients with opioid use disorders treated with buprenorphine","volume":"109","author":"Tsui","year":"2020","journal-title":"Journal of Substance Abuse Treatment"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875922000054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875922000054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:40:32Z","timestamp":1762652432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875922000054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":32,"alternative-id":["S2949875922000054"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2022.208934","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methamphetamine use and illicit opioid use during buprenorphine treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2022.208934","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"208934"}}